AzTrials
AzTrials

Anastomotic Leak Small IntestineDOUBLE CHECKNCT05250882

Enhanced Perioperative Care for the Prevention of Colorectal Anastomotic Leakage

A study testing Enhanced perioperative care protocol in people with Anastomotic Leak Small Intestine and Anastomotic Leak Large Intestine, run by Amsterdam UMC, location VUmc at 9 sites in 2 countries.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This multicenter open-label trial is designed to evaluate if the implementation of an enhanced peri-operative care protocol results in an optimal intraoperative condition of the patient and in a decrease in incidence of anastomotic leakage after colorectal resection as compared to current practice. Read more about this study

Who is it for?
Any age
What is being tested?
Enhanced perioperative care protocol
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,600 participants
Where
9 sitesin 2 countries
Study dates
5 Sep 2021to 1 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Age 18 and above
  • Bowel (small intestine/colon/rectal) resection with creation of a primary anastomosis
  • Ability to give informed consent

Who cannot join

  • The need for emergency surgery
  • Scheduled operation concerning a reoperation for complications from recent surgery (within 3 months after the initial procedure).
  • The inability to read or understand informed consent material

Trial locations and contacts

9 sites in 2 countries.

9 sites in 2 countries

Netherlands8 sites
  • Jeroen Bosch Ziekenhuis

    's-Hertogenbosch, North Brabant

  • Amsterdam UMC

    Amsterdam, North Holland

  • Elkerliek

    Helmond, Limburg

  • Dijklander Ziekenhuis

    Hoorn, North Holland

  • Maastricht UMC+

    Maastricht, Limburg

  • ZorgSaam

    Terneuzen, Zeeland

  • Bernhoven

    Uden, North Brabant

  • Maxima Medisch Centrum

    Veldhoven, North Brabant

Other trials in Netherlands

Belgium1 site
  • UZA

    Antwerp

Other trials in Belgium

About this study

Official title: Enhanced Perioperative Care for Improving Outcomes After Colorectal Resection by Implementation of Best Practice for the Prevention of Anastomotic Leakage - Double Check Study: Protocol for a Multicenter Open-label Trial

This multicenter open-label trial is designed to evaluate if the implementation of an enhanced peri-operative care protocol results in an optimal intraoperative condition of the patient and in a decrease in incidence of anastomotic leakage after colorectal resection as compared to current practice.

Read the detailed description

Rationale Colorectal anastomotic leakage (CAL) remains a severe complication following surgery with a reported incidence of 3-19% worldwide. Recent research has identified several modifiable peri-operative CAL risk factors, suggesting that the intraoperative condition of the patient plays an important role in CAL development.

Objective To successfully implement an enhanced perioperative care protocol, focusing on optimizing the intraoperative condition of the patient to minimalize exposure to CAL risk factors. Secondly, to investigate whether implementation of this new guideline results in a better intraoperative condition and a decreased CAL rate as compared to current practice.

Study design An open-label multicenter design with historical cohort in nine participating hospitals.

Study population All adult patients that are scheduled for a colorectal resection with creation of a primary anastomosis.

Intervention An enhanced perioperative best practice protocol. The Double Check bundle exists out of interventions applicable without the introduction of new material to the operating room, on top of usual care. The protocol is based on the results of our previous large, multicenter, international observational cohort study (LekCheck study), systematic literature analyses, an inventory in current protocols on peri-operative care and expert opinion. Consensus is reached with colorectal surgeons from all participating centers. The final protocol was reviewed critically by experts in the field of colorectal surgery before implementation.

Comparison 1592 historical patients that were treated with standard practice (LekCheck study group). In addition the anastomotic leakage rates from the national registry of the period after the LekCheck study and before the start of the Double Check study will be used for comparison.

Endpoints Compliance to the study protocol, the patient's intraoperative condition and exposure to modifiable intraoperative risk factors, 30-day CAL and other postoperative complications according to Clavien-Dindo classification. Follow-up will be 90 days after colorectal resection.

Being tested
Enhanced perioperative care protocol
Keywords
Riskfactor, Colorectal resection, Intraoperative condition, Perioperative care
Medical subject headings
Intraoperative Awareness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Enhanced perioperative care protocolOther

    See arm/group description

Study groups in NCT05250882
Study groupRoleWhat they receive
Double Check enhanced perioperative care protocolExperimentalPerioperative care according to a best practice protocol focussing on optimizing the intraoperative condition of the patient and thereby minimalize exposure to 6 known modifiable independent intraoperative risk factors: anemia, hypothermia, epidural anesthesia, vasopressor drug administration, incorrect antibiotic prophylaxis and hyperglycemia.
Receives: Other: Enhanced perioperative care protocol
Current practiceNo interventionPerioperative care according to usual practice. Historical controls from the previously conducted LekCheck study will be used as replacement of a control arm.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of modifiable intraoperative CAL risk factors present during surgery as assessed by the DoubleCheck list

    The primary outcome of the study is the intraoperative condition of the patient measured by the number of modifiable intraoperative CAL risk factors present in the patient.

    During the operation, the Double Check list will be completed.

    The list exists of 6 risk factors of interest:

    • Anemia: haemoglobin level < 7,5 (women) or < 8.0 (men) mmol/L
    • Hypothermia: temperature <36 degrees Celcius
    • Hyperglycemia: glucose level >10 mmol/L
    • Ue of vasopressor drugs: yes
    • Epidural analgesia
    • Incorrect antibiotic prophylaxis: not administered within 15-60 minutes prior to incision

    The number of risk factors present will be counted and a score of 0 to 6 will be given to each individual patient.

    Measured: Intraoperative phase

Secondary outcomes (5)
  1. Colorectal anastomotic leakage (CAL)

    Defined as a grade B or C according to the ISREC classification

    Measured: 30 days after surgery

  2. Postoperative complications

    Defined as any adverse event occurring in the postoperative period until 30 days after surgery and graded according to the Dindo-Clavien classification

    Measured: 30 days after surgery

  3. Postoperative mortality

    Measured as rate of death at 30-day follow-up

    Measured: 30 days after surgery

  4. Hospital Stay

    Length of hospital and intensive care unit stay

    Measured: 30 days after surgery

  5. Readmission

    30-day readmission rate

    Measured: 30 days after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Feb 2022
  2. Study start5 Sep 2021
  3. Primary completion1 Sep 2023 (estimated)
  4. Study completion1 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Crossover
Model description
Open label multicenter trial with historic controls
Masking
None (open label)
Enrolment
1,600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05250882
Sponsor's protocol ID
2020.0634
Acronym
DOUBLE CHECK
Status last verified
Feb 2022
First submitted
20 Jan 2022
Last updated
22 Feb 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The datasets generated during and/or analysed during the current study are/will be available upon request from dr. F. Daams

Publications

  • Huisman DE, Reudink M, van Rooijen SJ, Bootsma BT, van de Brug T, Stens J, Bleeker W, Stassen LPS, Jongen A, Feo CV, Targa S, Komen N, Kroon HM, Sammour T, Lagae EAGL, Talsma AK, Wegdam JA, de Vries Reilingh TS, van Wely B, van Hoogstraten MJ, Sonneveld DJA, Veltkamp SC, Verdaasdonk EGG, Roumen RMH, Slooter GD, Daams F. LekCheck: A Prospective Study to Identify Perioperative Modifiable Risk Factors for Anastomotic Leakage in Colorectal Surgery. Ann Surg. 2022 Jan 1;275(1):e189-e197. doi: 10.1097/SLA.0000000000003853.

    PubMed 32511133
  • van Rooijen SJ, Huisman D, Stuijvenberg M, Stens J, Roumen RMH, Daams F, Slooter GD. Intraoperative modifiable risk factors of colorectal anastomotic leakage: Why surgeons and anesthesiologists should act together. Int J Surg. 2016 Dec;36(Pt A):183-200. doi: 10.1016/j.ijsu.2016.09.098. Epub 2016 Oct 15.

    PubMed 27756644
  • de Wit A, Bootsma BT, Huisman DE, Kazemier G, Daams F; Taskforce Anastomotic Leakage. Early detection and correction of preoperative anemia in patients undergoing colorectal surgery-a prospective study. Tech Coloproctol. 2025 Apr 5;29(1):92. doi: 10.1007/s10151-025-03131-5.

    PubMed 40186755

Questions about this trial

What is this clinical trial studying?

A study testing Enhanced perioperative care protocol in people with Anastomotic Leak Small Intestine and Anastomotic Leak Large Intestine, run by Amsterdam UMC, location VUmc at 9 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 9 sites in Netherlands, Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of modifiable intraoperative CAL risk factors present during surgery as assessed by the DoubleCheck list (time frame: Intraoperative phase). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05250882, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Feb 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in